Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial
White Bear Lake, Minnesota--(Newsfile Corp. - May 13, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices that leverage the ear's natural anatomy, today announces achieving the important milestone of successful activation of all 10 study participants' fully implanted Acclaim® cochlear implants in the first stage of the Company's pivotal clinical trial.
Brent Lucas, CEO of Envoy Medical commented: "We are excited to report the positive and meaningful progress of our pivotal clinical trial, which is currently on track and moving along as anticipated. We are optimistic we will be able to expand the study into the second and final stage during the fourth quarter of this year. We are also encouraged by the reported interest from people suffering from significant hearing loss who want to wait until a fully implanted cochlear implant is an option. We believe there is significant pent-up demand for fully implanted cochlear implants, and we are thrilled to be closer to meeting this unmet need."
About the Fully Implanted Acclaim® Cochlear Implant
We believe the fully implanted Acclaim Cochlear Implant ("Acclaim CI") is a first-of-its-kind hearing device. Envoy Medical's fully implanted technology includes a sensor designed to leverage the natural anatomy of the ear instead of a microphone to capture sound.
The Acclaim CI is designed to address severe to profound sensorineural hearing loss that is not adequately addressed by hearing aids. The Acclaim CI is expected to be indicated for adults who have been deemed adequate candidates by a qualified physician.
The Acclaim Cochlear Implant received the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) in 2019.
CAUTION The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use.
About the Esteem® Fully Implanted Active Middle Ear Implant (FI-AMEI)
The Esteem fully implanted active middle ear implant (FI-AMEI) is the only FDA-approved, fully implanted* hearing device for adults diagnosed with moderate to severe sensorineural hearing loss allowing for 24/7 hearing capability using the ear's natural anatomy. The Esteem FI-AMEI hearing implant is invisible and requires no externally worn components and nothing is placed in the ear canal for it to function. Unlike hearing aids, you never put it on or take it off. You can't lose it. You don't clean it. The Esteem FI-AMEI hearing implant offers true 24/7 hearing.
*Once activated, the external Esteem FI-AMEI Personal Programmer is not required for daily use.
Important safety information for the Esteem FI-AMEI can be found at: https://www.envoymedical.com/safety-information.
Additional Information and Where to Find It
Copies of the documents filed by Envoy Medical with the SEC may be obtained free of charge at the SEC's website at www.sec.gov.
Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-Looking statements may be identified by the use of words such as "estimate," "plan," "project," "forecast," "intend," "will," "expect," "anticipate," "believe," "seek," "target" or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. Such statements may include, but are not limited to, statements regarding the expectations of Envoy Medical concerning the outlook for its business, productivity, plans and goals for future operational improvements and capital investments; the timing and results of IRB approvals, site documents, logistics or activations, enrollments, follow-up visits, data, and clinical trials of the Acclaim CI, and the participation or any changes in participation of any subjects, institutions or healthcare professionals in such trials; the Acclaim CI being the first to market fully implanted cochlear implant; the safety, performance, and market acceptance of the Acclaim CI; and any information concerning possible or assumed future operations of Envoy Medical. The forward-looking statements contained in this press release reflect Envoy Medical's current views about future events and are subject to numerous known and unknown risks, uncertainties, assumptions and changes in circumstances that may cause its actual results to differ significantly from those expressed in any forward-looking statement. Envoy Medical does not guarantee that the events described will happen as described (or that they will happen at all). These forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to changes in the market price of shares of Envoy Medical's Class A Common Stock; changes in or removal of Envoy Medical's shares inclusion in any index; Envoy Medical's success in retaining or recruiting, or changes required in, its officers, key employees or directors; unpredictability in the medical device industry, the regulatory process to approve medical devices, and the clinical development process of Envoy Medical products; competition in the medical device industry, and the failure to introduce new products and services in a timely manner or at competitive prices to compete successfully against competitors; disruptions in relationships with Envoy Medical's suppliers, or disruptions in Envoy Medical's own production capabilities for some of the key components and materials of its products; changes in the need for capital and the availability of financing and capital to fund these needs; changes in interest rates or rates of inflation; legal, regulatory and other proceedings could be costly and time-consuming to defend; changes in applicable laws or regulations, or the application thereof on Envoy Medical; a loss of any of Envoy Medical's key intellectual property rights or failure to adequately protect intellectual property rights; the effects of catastrophic events, including war, terrorism and other international conflicts; and other risks and uncertainties set forth in the section entitled "Risk Factors" and "Cautionary Note Regarding Forward Looking Statements" in the Annual Report on Form 10-K filed by Envoy Medical on March 31, 2025, and in other reports Envoy Medical files, with the SEC. If any of these risks materialize or Envoy Medical's assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. While forward-looking statements reflect Envoy Medical's good faith beliefs, they are not guarantees of future performance. Envoy Medical disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based only on information currently available to Envoy Medical.
###
Investor Relations:Envoy Medical Investor RelationsInvestorRelations@envoymedical.com
Media Contact:Media@envoymedical.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/251836
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
HIVE Digital CEO Frank Holmes says U.S. crypto regulation needs AI
HIVE Digital CEO Frank Holmes says U.S. crypto regulation needs AI originally appeared on TheStreet. In an interview with TheStreet Roundtable, HIVE Digital Technologies Chairman Frank Holmes weighed in on the SEC's Crypto Task Force Roundtable, where Chair Paul Atkins emphasized moving from enforcement to formal rulemaking for crypto issuance, custody and trading. Holmes predicts artificial intelligence will be at the heart of those new guidelines — and he also assessed how a non-sellable treasury Bitcoin reserve might reshape markets. Holmes argued that AI and next-generation data processing will enable regulators to draft clear, comprehensive crypto rules. 'I think the US government today is much more using AI and the ability with the new Nvidia chips to take huge amounts of data and also come out and create rules and regulations,' he said. He pointed to jurisdictions such as Dubai and Bermuda, where AI-assisted frameworks have already taken hold, as models for U.S. authorities. Those 'little islands,' Holmes noted, 'function extremely well, they've had for several years now a crypto ecosystem that has regulations and rules.' Formalizing ground rules, he said, will help manage 'spectacular growth' and move beyond the current patchwork approach. Holmes recalled a board meeting in Paris where 'there were nine thousand people there spending a thousand dollars a ticket at the Louvre learning all about all these new meme coins. I didn't know most of them. I was just so impressed.' That level of enthusiasm, he maintained, underscores why comprehensive AI-driven rulemaking is essential: 'Some basic ground rules and regulations really will be helpful to see it flourish and prosper.' Turning to the March executive order directing the Treasury to build a non-sellable reserve of over 200,000 Bitcoin, Holmes said even partial execution could 'ignite Bitcoin — the confidence in the overall system.' He noted that a government-backed Bitcoin holding would improve price discovery, deepen market liquidity and reinforce investor trust. Addressing proposals to sell gold to fund the reserve, Holmes pushed back: 'That's like saying sell all my Andy Warhol art and I'm only going to go buy Brainwash. I'm not going to do that. I'll have both.' He explained that revaluing gold to market prices would alter key balance-sheet metrics and argued that pairing gold with Bitcoin 'makes it the most powerful currency in the world.' Holmes's insights point to a potential inflection point: AI-powered rulemaking could bring long-awaited clarity to U.S. crypto regulation, while a strategic Bitcoin reserve may redefine price discovery, liquidity and confidence across digital assets. HIVE Digital CEO Frank Holmes says U.S. crypto regulation needs AI first appeared on TheStreet on Jun 10, 2025 This story was originally reported by TheStreet on Jun 10, 2025, where it first appeared. Sign in to access your portfolio
Yahoo
36 minutes ago
- Yahoo
Been a victim of annuity fraud? Here's how to report scams
Annuities are often marketed as reliable retirement income tools, but the reality is more complicated. While annuities can be beneficial for the right person in the right situation, the industry is still dogged by a history of scams and unethical practices. These scams aren't always outright fraud. Sometimes they're technically legal but still predatory. Either way, these scams can be devastating. After all, your retirement savings are on the line. If you or someone you know is considering an annuity, it's essential to recognize the red flags. And if you've already been burned by a scam, it's important to understand your options. Here's everything you need to know. Annuity scams come in many forms. But the result is usually the same — the consumer loses money, access or trust. Here are four of the most common types of annuity-related frauds. Churning happens when an insurance agent convinces you to switch from one annuity to another — not because it benefits you, but because it generates a fat commission for them. The agent might claim the new product has better terms or features. But in reality, you're often hit with surrender charges, new lockup periods and subpar benefits. This kind of abuse violates state and federal rules requiring financial professionals to act in your best interests. However, some agents push annuities that clearly don't meet the needs of the client — and the results can be disastrous. In 2023, the Securities and Exchange Commission (SEC) accused advisor Jeffrey Cutter of deceiving clients by pushing certain annuities to earn over $9 million in undisclosed commissions. Cutter allegedly engaged in annuity churning — repeatedly encouraging clients to sell and replace annuities, even when it triggered costly surrender charges. After Paul and Sue Rosenau won the Powerball in 2008, they set up a charitable foundation and hired an advisor to help. But in 2024, the Financial Industry Regulatory Authority (FINRA) ordered Principal Securities to pay $7.3 million in damages after evidence showed one of their advisors steered the foundation into over $47 million in high-cost variable annuities — earning about $3.3 million from commissions in the process. These annuities offered little benefit to a tax-exempt nonprofit, while locking up funds and charging steep fees. Cheaper alternatives existed, such as index funds and mutual funds— but the advisor put his own financial interests ahead of his clients'. By 2017, despite a booming stock market, those investments had actually lost value — dropping from $28.3 million to $26.3 million. Another tragic example involves Jay Jacobson, an 84-year-old man with dementia who was sold $2 million worth of annuities he couldn't access, leading to his suicide. This kind of behavior is unethical at best and illegal at worst. But it still happens — especially when firms fail to supervise their agents. Scammers often hide behind impressive-sounding but meaningless titles like 'Certified Senior Advisor' or 'Annuity Consultant.' These labels may sound official, but they're often handed out by pay-to-play organizations with little or no training requirements. At seminars and over the phone, these fake titles are used to gain your trust. But the person giving you advice may not be qualified or legally required to act in your best interests. You can use FINRA's financial designations database to figure out what the letters after a financial advisor's name really mean. You'll see what training is needed (if any), continuing education requirements and if the organization behind the credential accepts complaints. That's helpful, considering the sheer number of titles in finance; there are over 200 designations logged in FINRA's database. Free dinner seminars may be marketed as educational, but they're usually sales pitches in disguise. Presenters may claim annuities are tax-free (they're not — they're tax-deferred), risk-free (also false) or 'better than a 401(k).' Some even claim an annuity is backed by the government. None of that's true. No investment is risk-free, and unlike an FDIC-insured bank account, annuities aren't backed by the federal government. Once you're in the room, though, the pressure ramps up. You may be asked to sign documents immediately or risk 'missing out' on a limited-time offer. These tactics are designed to override your ability to think clearly — or consult with someone you trust. Legitimate professionals won't mind if you want time to review documents or talk to someone else. If they act angry or annoyed, that's a huge red flag. Factoring companies promise quick cash in exchange for your future annuity payments. Here's how it works: You agree to sell your guaranteed stream of payments for a lump sum today — your chance to 'get cash now.' However, it's almost always a terrible deal. These companies can buy your payments for pennies on the dollar. In 2015, a Washington Post investigation exposed how factoring companies exploit vulnerable people with structured settlements — court-ordered agreements that pay out over time, often for life, similar to an annuity. The Post found that Access Funding, a Maryland-based firm, frequently targeted lead poisoning victims, many of whom were poor and young. Victims were often paid as little as 9 to 21 cents on the dollar of present value for their structured settlement payments. Future annuity payments, like future structured settlement payments, can be sold to factoring companies, which often use aggressive marketing. If you're struggling to pay medical bills or cover basic expenses, the pitch can feel like a real lifeline. But in reality, it's a trap. Getting scammed can be overwhelming, but you're not powerless. Here's what to do if you think you've been misled, exploited or outright defrauded. The first step is to report the scam. The sooner you act, the better your chances of stopping future damage and potentially recovering some of your money. If an insurance agent was involved, start by contacting your state insurance department. Many states have dedicated consumer protection units. You can usually file a complaint online or by phone. If the annuity had investment features — like variable returns tied to stock market performance — and was sold by a broker-dealer, you should also report the incident to the SEC and FINRA. You can file a complaint with the SEC here and with FINRA here. If the scam involved identity theft, impersonation or started online, file a fraud complaint with the Federal Trade Commission (FTC). The FTC tracks fraud patterns across the country and shares that data with law enforcement and other agencies to build legal cases. Even if you don't get your money back right away, creating a formal complaint builds a paper trail — and that can be critical if legal action is taken later. Don't try to untangle a financial scam by yourself — especially if large sums of money were involved. A qualified attorney who has experience with financial fraud, exploitation or elder abuse can help you sort out your options. They can review contracts, gather evidence and pursue compensation through individual lawsuits or class action suits. Legal action can also expose a wider network of fraud. If your advisor scammed you, they may have scammed others, too. A lawyer can help uncover additional victims. If you suspect financial abuse of an elderly person, some states have mandatory reporting laws and special legal procedures. Need help finding an attorney? Start with these resources: Find a lawyer through the National Academy of Elder Law Attorneys. Find free legal help through the American Bar Association. Visit to find information about your legal questions and access free legal forms. Annuity scams can drain your savings fast. Knowing how to spot the warning signs can help protect you from becoming a you sign anything, read the entire contract. If you don't understand it, don't sign anything. Always ask questions and get a second because someone says they're certified doesn't mean they are. FINRA's BrokerCheck is a free tool that lets you look up financial professionals and firms so you can verify their credentials, work history and any disciplinary someone's pushing you to make a decision immediately or warning that a deal won't last, walk away. It's a huge red you attend an educational event about retirement planning, assume there's a sales pitch coming. Bring a friend or family member for a second perspective. Don't sign anything on-site, and don't fall for too-good-to-be-true annuity contracts come with a free-look period — usually 10 to 30 days — where you can cancel without penalty. If something feels off after you sign, act fast and contact the insurance company directly to cancel it. Annuities can be a legitimate part of a retirement strategy, but it's important to be aware of misleading practices and outright scams in the industry. If you're buying an annuity, slow down, ask questions and verify everything. And if you've already been scammed, know your rights and the steps you can take to report the fraud. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
GitLab Inc (GTLB) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic AI ...
Revenue: $214.5 million, a 27% increase year-over-year. Non-GAAP Operating Margin: 12.2%, compared to negative 2.3% in the previous year. Adjusted Free Cash Flow: $104.1 million, with a margin of 49%. Non-GAAP Gross Margin: 90% for the quarter. Dollar-Based Net Retention Rate (DBNRR): 122%. Total Annual Recurring Revenue (ARR): 10,104 customers with ARR of at least $5,000. Customers with $100,000+ ARR: Increased 26% year-over-year to 1,288. Guidance for Q2 FY26 Revenue: $226 million to $227 million. Guidance for FY26 Revenue: $936 million to $942 million. Cash and Investments: $1.1 billion at the end of the quarter. Warning! GuruFocus has detected 4 Warning Signs with GTLB. Release Date: June 10, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. GitLab Inc (NASDAQ:GTLB) reported a 27% year-over-year increase in revenue, reaching $215 million for the first quarter. The company achieved a non-GAAP operating margin of 12%, highlighting significant year-over-year operating margin expansion. GitLab Inc (NASDAQ:GTLB) continues to see strong adoption of its AI-native DevSecOps platform, with strategic differentiators like cloud agnosticism and comprehensive solutions across the software development lifecycle. The company launched GitLab 18, introducing new product capabilities that enhance core DevOps, security, and AI functionalities. GitLab Inc (NASDAQ:GTLB) achieved FedRAMP Moderate authorization, which is expected to boost its public sector business with its Dedicated offering. The company's Q1 beat was described as one of the 'skinniest' since its IPO, indicating tighter performance margins. There was a noted deceleration in sequential customer adds, particularly in the $100,000 ARR cohort. GitLab Inc (NASDAQ:GTLB) experienced a back-end weighted linearity in the quarter, which could indicate potential challenges in deal closures. The company faces price sensitivity at the low end of the market, impacting new customer additions. Concerns were raised about the potential impact of AI on job growth in the software developer market, which could affect demand for GitLab's services. Q: How are customer conversations evolving with the rapid advancements in AI, particularly regarding code suggestion and completion? A: Bill Staples, CEO: Every customer conversation touches on AI. Customers are eager to use AI to enhance productivity, innovation, and quality. The market is rapidly evolving with new tools and techniques. Customers often experiment with multiple AI tools, including GitLab Duo, to find the best fit. This experimentation ultimately benefits GitLab, as more code creation leads to increased demand for GitLab's comprehensive platform for testing, validation, and deployment. Q: Can you explain the growth dynamics, given the fiscal Q1 results and the outlook for the year? A: Brian Robins, CFO: The quarter's results were as expected, with a mix favoring SaaS and back-end weighted linearity. The guidance remains unchanged, assuming consistent macroeconomic conditions. The growth in RPO, CRPO, and billings indicates strong underlying demand, despite a slightly narrower beat compared to previous quarters. Q: How is AI adoption affecting job growth in the software developer market, and what are the implications for GitLab? A: Bill Staples, CEO: AI is seen as a productivity enhancer rather than a job threat. Historically, advances in productivity have led to more opportunities. AI will likely increase the number of code creators and the volume of code, benefiting GitLab. Brian Robins, CFO, added that developer hiring is turning positive, and GitLab's market opportunity remains vast. Q: How does GitLab plan to capture value from AI-driven enhancements, given the current pricing model? A: Bill Staples, CEO: GitLab is focusing on creating value through AI by enhancing collaboration between humans and agents, maintaining security and privacy, and leveraging its unified platform for better context and outcomes. The introduction of Duo Chat and code suggestions in Premium and Ultimate tiers is part of a strategy to lower adoption barriers and provide a smooth upgrade path to more advanced AI capabilities. Q: What are the key differentiators in GitLab 18, and why were certain features included without additional charges? A: Bill Staples, CEO: GitLab 18 introduces centralized artifact management, improved CICD pipelines, and enhanced security features. The inclusion of Duo Chat and code suggestions in Premium and Ultimate tiers aims to eliminate adoption barriers and provide a seamless upgrade path. The strategy is to offer a friction-free AI experience, encouraging broader adoption and eventual upgrades to more comprehensive solutions. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
